ETF Plays for a Divided Midterm Elections
With a contentious midterms election season coming up, many anticipate a split government that could potentially impact the way ETF investors ride…
IHE
Pharmaceutical ETFs Could Maintain Their Momentum
Pharmaceutical stocks and sector-related exchange traded funds have enjoyed a great summer and the rally may continue to have legs. Over the…
July Could Be a Volatile Month for Pharma ETFs
Changing political winds and the seasonal period for drugmakers to hike their prices could trigger short-term volatility in pharmaceutical sector-related ETFs. The…
Get Lucky With 10 Saint Patrick’s Day ETFs
Well folks, it’s that special time of the year on Saturday: the green revolution, the grand day of Guinness, the celebration of corn…
Getting Defensive With Healthcare ETFs as Congress Moves to Replace Obamacare
Healthcare stocks and the corresponding exchange traded funds continue to spend time in the spotlight as the Republican-controlled Congress moves to replace…
Drug Makers, Pharma ETFs Face a Tough Earnings Season
The healthcare sector has been lackluster this earnings season, and without supporting factors such as price increases or increased mergers and acquisitions…
Good News for Healthcare ETFs After Dodging Obamacare Repeal
The healthcare sector, the third-largest sector weight in the S&P 500, and the related exchange traded funds such as the iShares U.S.…
Finding Pharmaceuticals ETFs With Rebound Potential
Like other healthcare exchange traded funds (ETFs), dedicated pharmaceuticals ETFs are struggling this year. While prescription drug sales, such as cialis professional…
17 Healthcare ETFs Investors Should Check Up On
The healthcare sector is the third-largest sector in the S&P 500 and has been a primary driver of the current bull market.…
Major Pharma Merger Boosts ETFs
Pharmaceuticals giant Pfizer (NYSE: PFE) is in talks to acquire specialty drugmaker Allergan (NYSE: AGN) in what may be the biggest mergers…
ETFs to Capitalize Off Obamacare Fueled Growth
As the Affordable Care Act adds millions into the healthcare system, the increased demand for health products and services are supporting the…
M&A Activity Will Support Pharma ETFs Through Rising Rate Environment
Even if the Federal Reserve begins hiking interest rates later this year, the healthcare sector, notably pharmaceutical stocks and related exchange traded…
Healthcare ETFs: Specialized Drugs in Greater Demand
Johnson & Johnson (NYSE: JNJ), a major component of healthcare sector exchange traded funds, will enjoy greater sales of its specialized drugs.…
Investors Can Still Find Growth in Healthcare ETFs
While U.S. stocks are beginning to slow, investors can still find opportunities in healthcare sector exchange traded funds. “A clear sign of…